Pharmaceutical Science Update

November 22, 2017

First Gene Editing Clinical Trials in U.S. Could Start Next Year

The first U.S. clinical trials applying a technology called gene editing to mutations causing serious diseases could be up and running by next year, a scientist told a Senate panel on Nov. 14.

Related Stories